{"id":140936,"date":"2024-12-18T12:27:58","date_gmt":"2024-12-18T06:57:58","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=140936"},"modified":"2024-12-18T12:28:01","modified_gmt":"2024-12-18T06:58:01","slug":"pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/","title":{"rendered":"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3321729282\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&amp;D, cost-effective manufacturing, and a skilled workforce.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-409139478\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Companies like Sun Pharma, Dr. Reddy\u2019s, Cipla, and Lupin lead the sector. With increasing healthcare spending, rising chronic diseases, and export demand, India\u2019s pharma industry has immense growth potential, especially in biotechnology, biosimilars, and innovative drug development.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>India: The CDMO Capital of the World&nbsp;<\/strong><\/h2><p>India is known as the &#8220;CDMO (Contract Development and Manufacturing Organization) capital of the world,&#8221; dominating the global pharmaceutical outsourcing market. Indian companies provide end-to-end solutions, including drug development, manufacturing, and packaging, to major global pharma players.&nbsp;<\/p><p>The country\u2019s competitive pricing, skilled workforce, and regulatory expertise make it the preferred hub for outsourced pharmaceutical services. Prominent CDMOs like Lonza, Cipla, and Biocon contribute significantly to India&#8217;s position as a leading provider of contract services.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-434983767\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>India&#8217;s Push for Self-Reliance in API Manufacturing&nbsp;<\/strong><\/h2><p>India\u2019s pharmaceutical industry heavily relies on Active Pharmaceutical Ingredients (APIs), with China being a major supplier. However, India is now prioritizing self-reliance in API production to reduce this dependency.&nbsp;<\/p><p>By boosting domestic manufacturing capabilities and creating more robust supply chains, India aims to safeguard its pharmaceutical sector and reduce vulnerability to geopolitical risks. This push for self-reliance is critical in ensuring a consistent supply of high-quality medicines both domestically and globally.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price&nbsp;<\/strong><\/h2><p>The shares of<strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/BAJAJHCARE\" target=\"_blank\" rel=\"noreferrer noopener\"> Bajaj Healthcare<\/a><\/strong> hit an Upper circuit of 20% at Rs. 563.1 as of December 18, 2024. The stock has also given a return of more than 40% in December 2024\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent Updates&nbsp;<\/strong><\/h2><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Bajaj Healthcare\u2019s New CDMO Contract&nbsp;<\/strong><\/h2><p>Bajaj Healthcare Limited entered into a definitive CDMO contract with UK\/EU-based companies for 15 new APIs last week. This addition complements the earlier agreement made in February 2024, expanding the company\u2019s footprint in the global pharmaceutical market. The new pipeline\u00a0 includes both off-patent generic APIs and patented molecules, reinforcing the company\u2019s diverse portfolio.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Strengthening Manufacturing and R&amp;D Capabilities&nbsp;<\/strong><\/h2><p>Mr. Anil Jain, Managing Director of Bajaj Healthcare, highlighted the company\u2019s commitment to cost-effective synthesis routes and manufacturing expansion. With facilities approved by USFDA, EU, and now TGA Australia, the company is poised for greater growth in global markets, particularly in Australia, New Zealand, and South Africa.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Importance of a Strong API Order Book&nbsp;<\/strong><\/h2><p>A robust order book for APIs is crucial for sustaining long-term growth and profitability. The expansion of Bajaj Healthcare\u2019s order pipeline reflects its growing influence in the global pharmaceutical industry, ensuring continued demand for high-quality, cost-effective APIs.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-3146056153\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the Company&nbsp;<\/strong><\/h2><p>Incorporated in 1993, Bajaj Healthcare Ltd (BHL) is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Formulations. The company specializes in the development, supply, and manufacturing of Amino Acids, Nutritional Supplements, and APIs for the pharmaceutical, nutraceutical, and food industries.&nbsp;<\/p><p>BHL produces a wide range of formulations, including tablets, capsules, and powders, catering to over 550 clients globally. With exports to more than 62 countries across Europe, the USA, Africa, Australia, and other regions, Bajaj Healthcare has established a strong international presence, known for its high-quality products and commitment to innovation in the healthcare sector.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By: Dipangshu Kundu&nbsp;<\/strong><\/p><\/blockquote><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-2150331452\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25548,16926,16925,25549,948,936],"class_list":["post-140936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-bajaj-healthcare","tag-bajaj-healthcare-latest-news","tag-bajaj-healthcare-share-price","tag-pharma-stock-hits-upper-cicruit","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&amp;D, cost-effective manufacturing, and a skilled workforce.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies\" \/>\n<meta property=\"og:description\" content=\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&amp;D, cost-effective manufacturing, and a skilled workforce.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-18T06:57:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T06:58:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/\",\"name\":\"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-12-18T06:57:58+00:00\",\"dateModified\":\"2024-12-18T06:58:01+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&D, cost-effective manufacturing, and a skilled workforce.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies - Trade Brains Features","description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&D, cost-effective manufacturing, and a skilled workforce.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies","og_description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&D, cost-effective manufacturing, and a skilled workforce.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-18T06:57:58+00:00","article_modified_time":"2024-12-18T06:58:01+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/","name":"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-12-18T06:57:58+00:00","dateModified":"2024-12-18T06:58:01+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The Indian pharmaceutical industry is a global leader, ranking third in volume and 14th in value, with a market size of over $50 billion. Known as the \u201cpharmacy of the world,\u201d it supplies 20% of global generic medicines and is a key player in vaccines, exporting to over 200 countries. The industry is driven by strong R&D, cost-effective manufacturing, and a skilled workforce.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-hits-20-upper-circuit-after-receiving-15-api-contracts-from-uk-and-eu-based-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock hits 20% upper circuit after receiving 15 API contracts from UK and EU based companies"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=140936"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140936\/revisions"}],"predecessor-version":[{"id":140937,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/140936\/revisions\/140937"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=140936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=140936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=140936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}